W. Roberts

发表

GATA3 risk alleles are associated with ancestral components in Hispanic children with ALL.

A. Chokkalingam, L. Barcellos, P. Buffler, 2013, Blood.

A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma

Karl J. Dykema, J. Trent, S. Byron, 2022, Cancer reports.

Effects of a unique pediatric hematology–oncology palliative care program on medical decision-making and communication between healthcare providers and families: Results of a supportive care survey

C. Kline, J. Willert, W. Roberts, 2012 .

Improving vitamin D testing and supplementation in children with newly diagnosed cancer: A quality improvement initiative at Rady Children's Hospital San Diego

C. Thornburg, E. Fisher, W. Roberts, 2021, Pediatric blood & cancer.

Medulloblastoma With Extensive Nodularity: Tailored Therapy in a Low-resource Setting

M. Levy, J. Crawford, W. Roberts, 2017, Journal of pediatric hematology/oncology.

Identification of Drug Combinations Containing Imatinib for Treatment of BCR-ABL+ Leukemias

Andrew P. Hodges, Giovanni Paternostro, Edison Ong, 2014, PloS one.

Temozolomide and Radiation for Aggressive Pediatric Central Nervous System Malignancies

H. Meltzer, B. Kerlin, A. Geddis, 2005, Journal of pediatric hematology/oncology.

Sociodemographic and clinical characteristics associated with vitamin D status in newly diagnosed pediatric cancer patients

C. Thornburg, P. Zage, M. Martínez, 2020, Pediatric hematology and oncology.

3-amino thioacridone inhibits DNA synthesis and induce DNA damage in T-cell acute lymphoblastic leukemia (T-ALL) in a p16-dependent manner.

M. Diccianni, J. Pullen, John Yu, 2005, Journal of experimental therapeutics & oncology.

Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma

M Beth McCarville, N. Daw, W. Furman, 2008, Cancer.

Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B‐cell acute lymphoblastic leukemia

I. Smirnov, A. Chokkalingam, L. Barcellos, 2014, American journal of hematology.

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma

V. Brown, J. Foley, D. Eslin, 2020, International journal of cancer.

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

K. Neville, J. Foley, D. Eslin, 2018, Scientific Reports.

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma

K. Neville, D. Eslin, E. Gerner, 2015, PloS one.

Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion

J. Trent, Jun S. Wei, S. Szelinger, 2021, Cancer Research.

A Pilot Trial Testing the Feasibility of Using Molecular-Guided Therapy in Patients with Recurrent Neuroblastoma

Jeremy Miller, David Cherba, Joel Kaplan, 2012 .

A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma

D. Eslin, T. Ashikaga, T. Higgins, 2016, Pediatric blood & cancer.

Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma

Jason J. Corneveaux, J. Trent, K. Neville, 2015, Cancer medicine.

Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children

I. Smirnov, Philippe P Roux, R. Mckean-Cowdin, 2019, Genes, chromosomes & cancer.

Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library.

Giovanni Paternostro, Stefano Tiziani, G. Paternostro, 2011, Nature communications.

Metabolomics of the Tumor Microenvironment in Pediatric Acute Lymphoblastic Leukemia

Giovanni Paternostro, Carlo Piermarocchi, Stefano Tiziani, 2013, PloS one.

Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.

K. Weinberg, G. Annett, W. Roberts, 1994, Leukemia.

Improving Pediatric Neuro-Oncology Survival Disparities in the United States–Mexico Border Region: A Cross-Border Initiative Between San Diego, California, and Tijuana, Mexico

M. Levy, C. Thornburg, J. Crawford, 2020, JCO global oncology.

Addressing regional disparities in pediatric oncology: Results of a collaborative initiative across the Mexican–North American border

R. Ribeiro, C. Rodríguez-Galindo, W. Roberts, 2017, Pediatric blood & cancer.

Improving Pediatric Cancer Care Disparities Across the United States–Mexico Border: Lessons Learned from a Transcultural Partnership between San Diego and Tijuana

R. Ribeiro, W. Roberts, P. Aristizabal, 2015, Front. Public Health.

Reactivation of TWIST1 contributes to Ewing sarcoma metastasis

W. Roberts, R. Newbury, Jing Yang, 2018, Pediatric blood & cancer.

Fit4Life: A weight loss intervention for children who have survived childhood leukemia

Jeannie S. Huang, K. Patrick, G. Norman, 2014, Pediatric blood & cancer.

Improving Vitamin D testing and supplementation in children with newly-diagnosed cancer: A Quality Improvement Initiative at Rady Children’s Hospital San Diego

C. Thornburg, E. Fisher, D. Kuo, 2021 .

Childhood Leukemia Survival in the US-Mexico Border: Building Sustainable Leukemia Care Using Health Systems Strengthening Models

W. Roberts, P. Aristizabal, Raul C. Ribeiro, 2023, JCO global oncology.

Capacity-building initiative to improve clinical outcomes in pediatric acute lymphoblastic leukemia in the US-Mexico border region

R. Ribeiro, W. Roberts, P. Aristizabal, 2017 .

A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma

D. Eslin, P. Zage, T. Higgins, 2023, International journal of cancer.